Results - 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Hari Chemicals Export Ltd reported its Q2 and H1 FY26 results on November 14, 2025. Standalone revenue from operations jumped sharply to Rs. 744.50 lakhs in Q2 FY26 (vs Rs. 362.86 lakhs in Q2 FY25, a 105% rise) and Rs. 988.40 lakhs for H1 FY26 (vs Rs. 671.54 lakhs, ~47% growth). However, profitability was mixed: Standalone Q1 FY26 posted a loss of Rs. 167.39 lakhs, dragging H1 performance. Consolidated Q2 FY26 PAT recovered strongly to Rs. 352.60 lakhs, but H1 FY26 consolidated PAT came in at around Rs. 185.22 lakhs versus ~Rs. 243 lakhs in H1 FY25, a YoY decline. Consolidated operating cash flow turned negative at Rs. (15.07) lakhs for H1 FY26, although financing inflows from convertible debentures kept the overall cash balance positive. SEIAA granted environmental clearance to wholly owned subsidiary Shakambhari Dyechem for manufacturing synthetic organic chemicals and dye intermediates.
Strong top-line growth signals demand recovery, but the Q1 loss, negative consolidated operating cash flow, and YoY PAT decline indicate margin pressure and weak cash generation. Shareholders should watch whether the strong Q2 rebound sustains and whether operating cash flow improves in upcoming quarters.